newsfilter
← Latest News
GlobeNewswire·

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB:OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic